Aarti Drugs shares jump 11% after USFDA’s clearance for its Tarapur facility

The FDA inspection on its Tarapur facility, conducted earlier this year, has been concluded as “closed,” with the inspection classification designated as “voluntary action indicated” (VAI).

Leave a Reply

Your email address will not be published. Required fields are marked *